Margot Lindsay is a partner in our global M&A and Corporate practice based in London.
She advises listed companies, private companies, financial sponsors and international corporates on international and domestic public and private M&A, joint ventures, reorganisations and general corporate advisory matters.
Margot has broad experience across a range of industries.
Prior to joining White & Case, Margot worked for one of the UK's magic circle law firms for 8 years.
Representation of Morgan Stanley Infrastructure Partners on its £378.9 million competitive takeover offer for Augean plc
Representation of Aroundtown SA on its €1.57 billion takeover offer for Globalworth Real Estate Investments Limited as part of a consortium with CPI Property Group
Representation of discoverIE Group plc on the sale of its Custom Supply distribution business (Acal BFi) to H2 Equity Partners
Representation of Avon Protection plc on its Listing Rule class 1 acquisition of Team Wendy
Representation of Avon Protection plc on its Listing Rule class 2 disposal of its Milkrite | interpuls business to Tetra Laval
Representation of Avon Protection plc on its Listing Rule class 2 acquisition of 3M's US ballistic protection business
Representation of MOL Hungarian Oil and Gas PLC on its US$1.57 billion acquisition of Chevron's 9.57 percent stake in the Azeri-Chirag-Gunashli oil field in the Caspian Sea off Azerbaijan and an effective 8.90 percent interest in the Baku-Tbilisi-Ceyhan pipeline running across Azerbaijan, Georgia and Türkiye
Representation of ASX and AIM-listed European Metals, in the sale of the majority of its Czech Cinovec Lithium Project to Czech-utility CEZ
Representation of J Sainsbury plc on its proposed £15 billion merger with Asda*
Representation of Reckitt Benckiser Group plc on its US$17.9 billion acquisition of Mead Johnson Nutrition Company*
Representation of UBM plc on its takeover by Informa plc for £3.8 billion*
Representation of Novartis on its innovative asset swap with GSK, including the sale of its vaccines business to GSK, the purchase of GSK's oncology business and the contribution of its OTC business to a joint venture with GSK and the disposal of its influenza vaccines business to CSL*
Representation of Takeda Pharmaceuticals on the US$578 million sale of its global respiratory product portfolio to AstraZeneca*
* Experience prior to joining White & Case